Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
Presentation · Apr 2025 · PDF
BBIO - Canavan GTx BBP-812 - NTSAD 2025 - CANaspire Program Updates
Presentation · Apr 2025 · PDF
ACC 2025, Acoramidis-Mediated Early Increase in Serum Transthyretin: Insights From the ATTRibute-CM Study, Sarswat
Presentation · Apr 2025 · PDF
ACC 2025, Serum TTR Levels With Acoramidis in Patients With Variant Transthyretin Amyloid Cardiomyopathy, Davis
Presentation · Apr 2025 · PDF
ACC 2025, Acoramidis in ATTRibute-CM: Prespecified NT-proBNP Sensitivity Analyses of the Primary Endpoint, Griffin
Presentation · Apr 2025 · PDF
ACC 2025, NYHA Class at Month 30 With Acoramidis in Patients With ATTR-CM: Results From ATTRibute-CM, Alexander
Presentation · Mar 2025 · PDF